Generated by Rank Math SEO, this is an llms.txt file designed to help LLMs better understand and index this website.

# disrupting.healthcare

## Sitemaps
[XML Sitemap](https://disrupting.healthcare/sitemap_index.xml): Includes all crawlable and indexable pages.

## Posts
- [Europe Life Sciences Weekly Signal #40: The Bottleneck Moves Downstream](https://disrupting.healthcare/2026/06/07/europe-life-sciences-weekly-brief-40-bottleneck-moves-downstream/): Week of 1–7 June 2026
- [Europe Life Sciences Weekly Signal #39 Acquiring Is Not Operating](https://disrupting.healthcare/2026/05/31/europe-life-sciences-weekly-signal-39-acquiring-is-not-operating/): Week of 25–31 May 2026
- [Europe Life Sciences Weekly Signal #38: Where Launches Are Really Decided](https://disrupting.healthcare/2026/05/24/europe-life-sciences-weekly-signal-38-where-launches-are-decided/): Week of 18–24 May 2026
- [Europe Life Sciences Weekly Signal #37: When the Operating Layer Becomes the Strategy](https://disrupting.healthcare/2026/05/17/europe-life-sciences-weekly-signal-37-operating-layer-strategy/): The procedural week was supposed to be quiet. It was anything but.
- [Europe Life Sciences Weekly Signal #36: Buying Capability, Earning the Outcome](https://disrupting.healthcare/2026/05/10/europe-life-sciences-weekly-signal-36-buying-capability-earning-outcome/): Week of 4–10 May 2026
- [Europe Life Sciences Weekly Signal #35: Access Plumbing Becomes Strategy](https://disrupting.healthcare/2026/05/03/europe-life-sciences-weekly-signal-35-access-plumbing-strategy/): Week of 27 April–3 May 2026
- [Europe Life Sciences Weekly Signal #34](https://disrupting.healthcare/2026/04/26/europe-life-sciences-weekly-signal-34/): Week of 20–26 April 2026
- [Europe Life Sciences Weekly Signal #33](https://disrupting.healthcare/2026/04/19/europe-life-sciences-weekly-signal-33/): Week of 13–19 April 2026
- [Europe Life Sciences Weekly Brief](https://disrupting.healthcare/2026/04/12/europe-life-sciences-weekly-brief-april-6-12-2026/): Week of 6–12 April 2026 (#32)
- [Europe Life Sciences Weekly Brief – Sovereign Cloud, Biogen’s Apellis Bet, and Europe’s Tightening Execution Layer](https://disrupting.healthcare/2026/04/05/europe-life-sciences-weekly-brief/): This was a week of infrastructure hiding in plain sight. A sovereign-cloud launch, a large rare-disease acquisition, EU funding for generative-AI cancer research, and a cluster of regulatory deadlines all pointed to the same underlying shift: life sciences is moving from digital ambition to execution architecture.
- [Europe Life Sciences Weekly Brief #30](https://disrupting.healthcare/2026/03/29/europe-medtech-weekly-brief-mar-23-29-2026/): Week of March 23–29, 2026
- [Agentic AI in Life Sciences Commercial: What Actually Changes in Your Operating Model](https://disrupting.healthcare/2026/03/27/agentic-ai-in-life-sciences-commercial-what-actually-changes-in-your-operating-model/): AI in Commercial Operations
- [Europe Life Sciences Weekly Brief #29 — AI in Hospitals, Cyber Risk, Diagnostics Consolidation](https://disrupting.healthcare/2026/03/22/europe-medtech-news-mar-16-22-2026/): This week wasn’t about innovation. It was about whether innovation survives contact with reality.
- [Top HealthTech Companies in Europe (2026)](https://disrupting.healthcare/2026/03/18/healthtech-companies-europe/): Europe’s healthtech ecosystem is no longer just “emerging.” In 2026, it is structurally reshaping how healthcare is delivered, financed, and optimized; from AI diagnostics to consumer wearables and digital-first care platforms.
- [MedTech Marketing in Europe: Why Omnichannel Still Fails](https://disrupting.healthcare/2026/03/16/medtech-marketing-europe-omnichannel/): Most medtech teams do not have a channel problem. They have an operating model problem. In Europe, where procurement, evidence, and market access vary wildly by country, omnichannel only works when commercial execution is designed as a system rather than a campaign.
- [Europe MedTech News: Waiv, Vitestro, MiniMed and EU AI Policy (Mar 9–15, 2026, #28)](https://disrupting.healthcare/2026/03/15/europe-medtech-news-waiv-vitestro-minimed-eu-ai-policy-mar-9-15/): This week’s Europe medtech news points to a market that is becoming less patient with vague AI platform stories and more interested in deployment readiness: products that fit workflows, evidence plans that survive scrutiny, and policy moves that reduce friction instead of adding more theatre.
- [Europe MedTech News: Xsensio funding, FARAPULSE CE mark, and UK NICE policy (Week of Mar 2-8, 2026, #27)](https://disrupting.healthcare/2026/03/08/europe-medtech-news-xsensio-funding-farapulse-ce-mark-and-uk-nice-policy-week-of-mar-2-8-2026-27/): A week in which Swiss sensors found deep pockets, “boring” logistics became interesting, and Europe’s commercialization machine kept reminding everyone that market access is only the beginning.
- [Europe MedTech & Digital Health Weekly Brief (Week of Feb 23–Mar 1, 2026, #26)](https://disrupting.healthcare/2026/03/01/europe-medtech-digital-health-weekly-brief-week-of-feb-23-mar-1-2026-26/): This week: Europe writes bigger cheques for edge AI, surgeons get sharper intra-op vision, and regulators quietly upgrade the “plumbing” that makes scale possible.
- [Europe MedTech & Digital Health Weekly Brief (Week of Feb 16-22, 2026, #25)](https://disrupting.healthcare/2026/02/22/europe-medtech-digital-health-weekly-brief-week-of-feb-16-22-2026-25/): Compliance tooling and workflow automation quietly had a massive week, capped off by the UK's loud return to the CE mark conversation with a push for indefinite regulatory recognition.
- [Europe MedTech & Digital Health Weekly Brief (Week of Feb 9–15, 2026, #24)](https://disrupting.healthcare/2026/02/16/europe-medtech-digital-health-weekly-brief-week-of-feb-9-15-2026-24/): European healthcare shifts from "growth at all costs" toward commercial execution as precision pathology, ocular structural integrity, and public-market readiness dominate the landscape.
- [Europe MedTech & Digital Health Weekly Brief (Week of Feb 2–8, 2026, #23)](https://disrupting.healthcare/2026/02/08/europe-medtech-digital-health-weekly-brief-week-of-feb-2-8-2026-23/): Clinical-trial AI cash, senior care safety tech, and a trio of MDR certifications: Europe’s week mixed capital, commercialization, and infrastructure-level digital transformation.
- [Breaking the “Rule 11” Bottleneck: The New Era for AI in Medical Imaging](https://disrupting.healthcare/2026/02/01/breaking-the-rule-11-bottleneck-the-new-era-for-ai-in-medical-imaging/): For years, European imaging AI founders have been trapped by Rule 11 of the MDR, which effectively pushed almost all diagnostic software into Class IIa or higher. However, the regulatory landscape shifted dramatically this week as the European Commission's simplification proposal moved toward implementation, signaling a fundamental win for the digital health sector.
- [Europe MedTech & Digital Health Weekly Brief (Week of Jan 26 – Feb 1, 2026, #22)](https://disrupting.healthcare/2026/02/01/europe-medtech-digital-health-weekly-brief-week-of-jan-26-feb-1-2026-22/): The European ecosystem is trading complexity for clarity this week: a landmark proposal to "de-clog" the MDR/IVDR bottleneck arrives alongside major CE marks in diabetes, while surgical imaging and pharmacy infrastructure secure fresh growth capital to scale.
- [Europe MedTech & Digital Health Weekly Brief (Week of Jan 19–26, 2026, #21)](https://disrupting.healthcare/2026/01/26/europe-medtech-digital-health-weekly-brief-week-of-jan-19-26-2026-21/): A heavyweight week for the "reimbursement-first" era: chronic care platforms are hitting mega-round scale, NICE is formalizing the digital MSK pathway, and a French-made mitral valve just secured its ticket to the EU market.
- [EMA & FDA’s 10 AI Principles. What EU MedTech Founders Must Do Now](https://disrupting.healthcare/2026/01/23/ema-fdas-10-ai-principles-what-eu-medtech-founders-must-do-now/): It’s not a binding guidance, but it’s the clearest signal yet of how EU and U.S. reviewers want AI-supported evidence generated and governed. EMA news ; FDA page; PDF
- [Europe MedTech & Digital Health Weekly Brief (Week of Jan 12–18, 2026, #20)](https://disrupting.healthcare/2026/01/18/europe-medtech-digital-health-weekly-brief-week-of-jan-12-18-2026-20/): Quiet but productive: seed checks for prevention and preclinical tools, one neat CE mark, and a fresh EU call.
- [Europe MedTech & Digital Health Weekly Brief (Week of Dec 13–19, 2025, #19)](https://disrupting.healthcare/2025/12/19/europe-medtech-digital-health-weekly-brief-week-of-dec-13-19-2025-19/): This week: primary-care “rollup + AI” gets real money, non-invasive metabolic wearables keep attracting believers, and Brussels finally brought out the MDR/IVDR wrench set. It is silent for the end year festive break. Note, that also our weekly brief will stop until 9th of January.
- [Europe MedTech & Digital Health Weekly Brief (Week of Dec 6–12, 2025, #18)](https://disrupting.healthcare/2025/12/12/europe-medtech-digital-health-weekly-brief-week-of-dec-6-12-2025-18/): Deal flow picked up: cardiology workflow hardware gets a seasoned chair, obesity tech hits a pivotal milestone, and Europe leans into AI—from a €10m cross-border programme to NICE nudging digital MSK tools forward.
- [Europe MedTech & Digital Health Weekly Brief (Week of Nov 29–Dec 5, 2025, #17)](https://disrupting.healthcare/2025/12/05/europe-medtech-digital-health-weekly-brief-week-of-nov-29-dec-5-2025-17/): A compact week: venture debt fuels vascular access, cardiology gets a non-invasive CE mark, and NICE nudges digital rehab platforms toward the NHS.
- [Best Countries to Launch or Scale a HealthTech Startup in Europe (2025)](https://disrupting.healthcare/2025/11/30/best-countries-to-launch-or-scale-a-healthtech-startup-in-europe-2025/): If you ask ten founders where to launch a healthtech startup in Europe, eight will say Berlin, one will say London, and one will whisper Lisbon for “quality of life reasons”. They’re all partially right and all are missing the bigger picture.
- [Europe MedTech & Digital Health Weekly Brief – Funding, AI Act & Imaging (Week of Nov 22–28, 2025, #16)](https://disrupting.healthcare/2025/11/28/europe-medtech-digital-health-weekly-brief-funding-ai-act-imaging-week-of-nov-22-28-2025-16/): Ergea Group (Luxembourg)New CEO for pan-European imaging & cancer care
- [2024 vs 2025: Where the Money’s Really Coming From in European HealthTech](https://disrupting.healthcare/2025/11/26/2024-vs-2025-where-the-moneys-really-coming-from-in-european-healthtech/): If you work in HealthTech in Europe, you’ve probably noticed something strange. 2024 felt like the world was ending, yet the actual numbers say something very different.Capital didn’t disappear — it simply stopped tolerating nonsense.
- [Europe MedTech & Digital Health Weekly Brief (Week of Nov 15–21, 2025, #15)](https://disrupting.healthcare/2025/11/21/europe-medtech-digital-health-weekly-brief-week-of-nov-15-21-2025-15/): Robotics bags big money, IVF gets an automation CE mark, and UK regulators sketch next steps for AI in care.
- [Preventive diagnostics meets subscription-living: lessons from the US and Europe](https://disrupting.healthcare/2025/11/18/preventive-diagnostics-meets-subscription-living-lessons-from-the-us-and-europe/): The paradigm in healthcare is shifting: instead of “see a doctor when things go wrong”, some start-ups are betting the future lies in “continuous health monitoring for when things haven’t yet gone wrong”. The US model is blazing ahead; Europe is watching with interest and caution.
- [Europe MedTech & Digital Health Weekly Brief (Week of Nov 8–14, 2025, #14)](https://disrupting.healthcare/2025/11/14/europe-medtech-digital-health-weekly-brief-week-of-nov-8-14-2025-14/): A compact week: small but pointed rounds in diagnostics and patient safety, a urology partnership scaling across EMEA, radiosurgery planning cleared on both sides of the Atlantic, and a headline corporate restructure.
- [Who’s Funding the Boom?](https://disrupting.healthcare/2025/11/07/whos-funding-the-boom/): Healthtech funding in Europe is accelerating again. After a cautious 2023, investment rebounded to $4.8 billion in 2024, and Q1 2025 alone brought in $4.3 billion. Healthtech now captures 30 to 35% of all venture activity across the continent. But who's actually writing those cheques?
- [Europe MedTech & Digital Health Weekly Brief (Week of Nov 1–7, 2025, #13)](https://disrupting.healthcare/2025/11/07/europe-medtech-digital-health-weekly-brief-week-of-nov-1-7-2025-13/): Cardio-adjacent robots, workflow expansions, and device commercialization: this week mixes a new fund backing medtech, a fresh CE mark, and EU market-surveillance tidings.
- [Europe MedTech & Digital Health Weekly Brief (Week of Oct 25–31, 2025, #12)](https://disrupting.healthcare/2025/10/31/europe-medtech-digital-health-weekly-brief-week-of-oct-25-31-2025-12/): AI pathology and precision health get fresh fuel; MDR CE marks stack up; MHRA drops safety signals and an IDAP tweak—another week of pilot-to-product momentum.
- [The Top 10 Most Valuable HealthTech Companies in Europe (2025)](https://disrupting.healthcare/2025/10/29/the-top-10-most-valuable-healthtechcompanies-in-europe-2025/): Let’s not pretend valuation is the ultimate success metric. But it is a decent proxy for where capital, confidence and commercial traction are flowing. Especially in a market as fragmented and overregulated as European healthcare.
- [Mapping the European HealthTech Goldmine](https://disrupting.healthcare/2025/10/28/mapping-the-european-healthtech-goldmine/): This is Mapping the European HealthTech Goldmine. A five-part series for anyone building, backing, or expanding healthtech in Europe.
- [Europe MedTech & Digital Health — Weekly Brief (Week of 18–24 Oct 2025, #11)](https://disrupting.healthcare/2025/10/24/europe-medtech-digital-health-weekly-brief-week-of-18-24-oct-2025-11/): Funding stacked, boards shuffled, CE marks landed — this week runs on neurotech raises, workflow monitors, and regulator backed AI.
- [Europe MedTech & Digital Health Weekly Brief (Week of 11–17 October 2025, #10)](https://disrupting.healthcare/2025/10/17/europe-medtech-digital-health-weekly-brief-week-of-11-17-october-2025-10/): Workflow AI meets breast imaging and structural heart trials: a week of pragmatic progress across funding, CE marks, and sandboxed regulation.
- [ZEISS, Ocumeda, and the Optical Trojan Horse:  Omnichannel in MedTech](https://disrupting.healthcare/2025/10/16/zeiss-ocumeda-and-the-optical-trojan-horse-omnichannel-in-medtech/): Omnichannel in MedTech usually means a half-baked app, an email campaign, or a portal nobody uses. ZEISS changed the script.
- [Europe MedTech & Digital Health Weekly Brief (Week of 4–10 October 2025, #9)](https://disrupting.healthcare/2025/10/10/europe-medtech-digital-health-weekly-brief-week-of-4-10-october-2025-9/): This week in European MedTech and Digital Health has seen steady progress, with notable funding rounds, product launches, regulatory milestones, and leadership changes. Key highlights include the debut of a new ECMO system, a cardiology AI solution achieving its CE mark, and enhanced regulatory cooperation between the UK and the US on AI and medical devices.
- [AI in EU Healthcare: Bureaucracy vs Opportunity](https://disrupting.healthcare/2025/10/07/ai-in-eu-healthcare-bureaucracy-vs-opportunity/): A deep dive into the EU Commission's latest findings on AI in healthcare. What MedTech founders and investors need to know in 2025.
- [Omnichannel in MedTech: What Europe’s Top Players Can Teach You](https://disrupting.healthcare/2025/10/04/omnichannel-in-medtech-what-europes-top-players-can-teach-you/): Everyone talks about omnichannel. Few do it well.
- [Europe MedTech & Digital Health Weekly Brief (Week of Sep 28–Oct 4, 2025, #8)](https://disrupting.healthcare/2025/10/04/europe-medtech-digital-health-weekly-brief-week-of-sep-28-oct-4-2025-7/): A brisk week: AI health coaching nets fresh capital, vet workflow AI gets a push, CE-marked remote monitoring scales, and Brussels opens the door for MDR/IVDR feedback.
- [Quantum Genomics: Hyper-Personalised Medicine or Just a Thought Experiment?](https://disrupting.healthcare/2025/09/28/quantum-genomics-hyper-personalised-medicine-or-just-a-thought-experiment/): Genomics is drowning in data. A single human genome contains over 3 billion base pairs, and personalised medicine requires mapping not just one genome but entire populations. Quantum algorithms promise to search and analyse these vast datasets faster than classical methods, identifying subtle gene–disease correlations that underpin cancers or rare conditions.
- [Europe MedTech & Digital Health — Weekly Brief (Week of Sep 20–26, 2025, #7)](https://disrupting.healthcare/2025/09/26/europe-medtech-digital-health-weekly-brief-week-of-sep-20-26-2025-6/): A brisk week: big wearable debt, a Finland-to-EU CE mark, and fresh regulatory momentum for tinnitus therapy—plus Medtronic doubles down on a London robotics and AI hub.
- [FAQ: AI Security in Healthcare](https://disrupting.healthcare/2025/09/26/faq-ai-security-in-healthcare/): AI can improve diagnostics, treatment recommendations, and patient monitoring but without safeguards it can be manipulated. Adversarial attacks on medical imaging AI have been shown to cause misclassifications (European Journal of Radiology).

## Pages
- [Life Sciences Commercial Transformation | Strategy, Market Intelligence & AI | disrupting.healthcare](https://disrupting.healthcare/): Commercialization, regulation, AI, and operating-model shifts shaping pharma, MedTech, and digital health in Europe - from an operator’s perspective.
- [Pharma & MedTech Guide to Quantum Computing](https://disrupting.healthcare/pharma-medtech-guide-to-quantum-computing/): quantum computing in healthcare, quantum drug discovery, quantum genomics, post-quantum cryptography healthcare, EU quantum healthcare, quantum commercialisation Europe.
- [The Complete Guide to Omnichannel Marketing in Pharma and Medtech](https://disrupting.healthcare/pharma-medtech-omnichannel-marketing-faq-series/): Welcome to Your Ultimate Resource for Omnichannel Marketing Excellence
- [SaMD Europe Launch Guide](https://disrupting.healthcare/samd-europe-launch-guide/): Welcome to the definitive guide to launching Software as a Medical Device (SaMD) in Europe.
- [Scaling MedTech: From Product to Market](https://disrupting.healthcare/scaling-medtech-from-product-to-market/): Welcome to our 5-part series on how to take your MedTech innovation from prototype to market-ready — and reimbursed.
- [About](https://disrupting.healthcare/about/): disrupting.healthcare is an independent publication focused on the future of health technology and pharma commercialization in Europe.

## MailPoet Page
- [MailPoet Page](https://disrupting.healthcare/?mailpoet_page=captcha)
- [MailPoet Page](https://disrupting.healthcare/?mailpoet_page=subscriptions)